Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer

Fiorella Magani, Eric R. Bray, Maria J. Martinez, Ning Zhao, Valeria A. Copello, Laine Heidman, Stephanie O. Peacock, David J. Wiley, Gennaro D'urso, Kerry L Burnstein

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Identifying critical pathways governing disease progression is essential for accurate prognosis and effective therapy. We developed a broadly applicable and novel systems-level gene discovery strategy. This approach focused on constitutively active androgen receptor (AR) splice variant-driven pathways as representative of an intractable mechanism of prostate cancer (PC) therapeutic resistance. We performed a meta-analysis of human prostate samples using weighted gene co-expression network analysis combined with experimental AR variant transcriptome analyses. An AR variant-driven gene module that is upregulated during human PC progression was identified. We filtered this module by identifying genes that functionally interacted with AR variants using a high-throughput synthetic genetic array screen in Schizosaccharomyces pombe. This strategy identified seven AR variant-regulated genes that also enhance AR activity and drive cancer progression. Expression of the seven genes predicted poor disease-free survival in large independent PC patient cohorts. Pharmacologic inhibition of interacting members of the gene set potently and synergistically decreased PC cell proliferation. This unbiased and novel gene discovery strategy identified a clinically relevant, oncogenic, interacting gene hub with strong prognostic and therapeutic potential in PC.

Original languageEnglish (US)
Article numbere8202
JournalMolecular Systems Biology
Volume14
Issue number8
DOIs
StatePublished - Aug 1 2018

Fingerprint

Prostate Cancer
Androgen Receptors
prostatic neoplasms
Prostatic Neoplasms
Genes
Gene
Receptor
therapeutics
genes
Gene Regulatory Networks
Genetic Association Studies
Progression
Therapeutics
Gene Expression
Critical Pathways
Schizosaccharomyces
Pathway
Gene Expression Profiling
Disease-Free Survival
Disease Progression

Keywords

  • androgen receptor splice variants
  • castration resistance
  • mitotic gene signature
  • weighted gene co-expression network analysis
  • yeast synthetic genetic array

ASJC Scopus subject areas

  • Information Systems
  • Biochemistry, Genetics and Molecular Biology(all)
  • Immunology and Microbiology(all)
  • Agricultural and Biological Sciences(all)
  • Computational Theory and Mathematics
  • Applied Mathematics

Cite this

Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer. / Magani, Fiorella; Bray, Eric R.; Martinez, Maria J.; Zhao, Ning; Copello, Valeria A.; Heidman, Laine; Peacock, Stephanie O.; Wiley, David J.; D'urso, Gennaro; Burnstein, Kerry L.

In: Molecular Systems Biology, Vol. 14, No. 8, e8202, 01.08.2018.

Research output: Contribution to journalArticle

Magani, F, Bray, ER, Martinez, MJ, Zhao, N, Copello, VA, Heidman, L, Peacock, SO, Wiley, DJ, D'urso, G & Burnstein, KL 2018, 'Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer', Molecular Systems Biology, vol. 14, no. 8, e8202. https://doi.org/10.15252/msb.20188202
Magani, Fiorella ; Bray, Eric R. ; Martinez, Maria J. ; Zhao, Ning ; Copello, Valeria A. ; Heidman, Laine ; Peacock, Stephanie O. ; Wiley, David J. ; D'urso, Gennaro ; Burnstein, Kerry L. / Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer. In: Molecular Systems Biology. 2018 ; Vol. 14, No. 8.
@article{3dfbf8638efd46d48c498989f62acec3,
title = "Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer",
abstract = "Identifying critical pathways governing disease progression is essential for accurate prognosis and effective therapy. We developed a broadly applicable and novel systems-level gene discovery strategy. This approach focused on constitutively active androgen receptor (AR) splice variant-driven pathways as representative of an intractable mechanism of prostate cancer (PC) therapeutic resistance. We performed a meta-analysis of human prostate samples using weighted gene co-expression network analysis combined with experimental AR variant transcriptome analyses. An AR variant-driven gene module that is upregulated during human PC progression was identified. We filtered this module by identifying genes that functionally interacted with AR variants using a high-throughput synthetic genetic array screen in Schizosaccharomyces pombe. This strategy identified seven AR variant-regulated genes that also enhance AR activity and drive cancer progression. Expression of the seven genes predicted poor disease-free survival in large independent PC patient cohorts. Pharmacologic inhibition of interacting members of the gene set potently and synergistically decreased PC cell proliferation. This unbiased and novel gene discovery strategy identified a clinically relevant, oncogenic, interacting gene hub with strong prognostic and therapeutic potential in PC.",
keywords = "androgen receptor splice variants, castration resistance, mitotic gene signature, weighted gene co-expression network analysis, yeast synthetic genetic array",
author = "Fiorella Magani and Bray, {Eric R.} and Martinez, {Maria J.} and Ning Zhao and Copello, {Valeria A.} and Laine Heidman and Peacock, {Stephanie O.} and Wiley, {David J.} and Gennaro D'urso and Burnstein, {Kerry L}",
year = "2018",
month = "8",
day = "1",
doi = "10.15252/msb.20188202",
language = "English (US)",
volume = "14",
journal = "Molecular Systems Biology",
issn = "1744-4292",
publisher = "Nature Publishing Group",
number = "8",

}

TY - JOUR

T1 - Identification of an oncogenic network with prognostic and therapeutic value in prostate cancer

AU - Magani, Fiorella

AU - Bray, Eric R.

AU - Martinez, Maria J.

AU - Zhao, Ning

AU - Copello, Valeria A.

AU - Heidman, Laine

AU - Peacock, Stephanie O.

AU - Wiley, David J.

AU - D'urso, Gennaro

AU - Burnstein, Kerry L

PY - 2018/8/1

Y1 - 2018/8/1

N2 - Identifying critical pathways governing disease progression is essential for accurate prognosis and effective therapy. We developed a broadly applicable and novel systems-level gene discovery strategy. This approach focused on constitutively active androgen receptor (AR) splice variant-driven pathways as representative of an intractable mechanism of prostate cancer (PC) therapeutic resistance. We performed a meta-analysis of human prostate samples using weighted gene co-expression network analysis combined with experimental AR variant transcriptome analyses. An AR variant-driven gene module that is upregulated during human PC progression was identified. We filtered this module by identifying genes that functionally interacted with AR variants using a high-throughput synthetic genetic array screen in Schizosaccharomyces pombe. This strategy identified seven AR variant-regulated genes that also enhance AR activity and drive cancer progression. Expression of the seven genes predicted poor disease-free survival in large independent PC patient cohorts. Pharmacologic inhibition of interacting members of the gene set potently and synergistically decreased PC cell proliferation. This unbiased and novel gene discovery strategy identified a clinically relevant, oncogenic, interacting gene hub with strong prognostic and therapeutic potential in PC.

AB - Identifying critical pathways governing disease progression is essential for accurate prognosis and effective therapy. We developed a broadly applicable and novel systems-level gene discovery strategy. This approach focused on constitutively active androgen receptor (AR) splice variant-driven pathways as representative of an intractable mechanism of prostate cancer (PC) therapeutic resistance. We performed a meta-analysis of human prostate samples using weighted gene co-expression network analysis combined with experimental AR variant transcriptome analyses. An AR variant-driven gene module that is upregulated during human PC progression was identified. We filtered this module by identifying genes that functionally interacted with AR variants using a high-throughput synthetic genetic array screen in Schizosaccharomyces pombe. This strategy identified seven AR variant-regulated genes that also enhance AR activity and drive cancer progression. Expression of the seven genes predicted poor disease-free survival in large independent PC patient cohorts. Pharmacologic inhibition of interacting members of the gene set potently and synergistically decreased PC cell proliferation. This unbiased and novel gene discovery strategy identified a clinically relevant, oncogenic, interacting gene hub with strong prognostic and therapeutic potential in PC.

KW - androgen receptor splice variants

KW - castration resistance

KW - mitotic gene signature

KW - weighted gene co-expression network analysis

KW - yeast synthetic genetic array

UR - http://www.scopus.com/inward/record.url?scp=85052513670&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052513670&partnerID=8YFLogxK

U2 - 10.15252/msb.20188202

DO - 10.15252/msb.20188202

M3 - Article

C2 - 30108134

AN - SCOPUS:85052513670

VL - 14

JO - Molecular Systems Biology

JF - Molecular Systems Biology

SN - 1744-4292

IS - 8

M1 - e8202

ER -